Mild to Moderate Ulcerative Colitis Clinical Trial
Official title:
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel, Dose-finding Phase II Clinical Study to Evaluate the Efficacy and Safety of SPH3127 Tablets in the Treatment of Mild to Moderate Ulcerative Colitis
To preliminarily evaluate the clinical efficacy of the renin inhibitor SPH3127 Tablets in patients with mild to moderate ulcerative colitis with placebo as a control and determine the recommended dose.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01201122 -
Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis
|
Phase 4 | |
Completed |
NCT01033305 -
Oral Ciclosporin for Colonic Release in Ulcerative Colitis (CyColâ„¢)
|
Phase 2 | |
Completed |
NCT01045018 -
A BE Study Comparing Mesalamine 400 mg to ASACOL® 400 mg in Patients With Mild To Moderately Active Ulcerative Colitis
|
Phase 3 | |
Recruiting |
NCT01039597 -
Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis
|
Phase 1/Phase 2 |